Novo Nordisk A/S has achieved a 20.8% annualized return over three decades, becoming Europe's largest company by market cap.The company efficiently managed the increased demand for obesity drugs, but ...
Source LinkNovo Nordisk A/S has achieved a 20.8% annualized return over three decades, becoming Europe's largest company by market cap.The company efficiently managed the increased demand for obesity drugs, but ...
Source Link
Comments